Abstract
Restless legs syndrome (RLS)/Willis-Ekbom disease (WEB) is a common sleep-related disorder affecting approximately 7% of the adult European and American population and 2% of children between 8–17 years old. It is described as an urge to move the legs when resting, with associated dysesthesia, and a circadian appearance. There is a higher prevalence of RLS cases in female sex, increasing age and patients with a positive family history. Other factors as iron deficiency, medications, chronic renal failure, pregnancy and immobility may precipitate and worsen symptoms. Many common classes of medications such as antihistamines and anticholinergics can exacerbate RLS symptoms. A histaminergic abnormality related to increased hypocretin has been the proposed mechanism for RLS exacerbation with antihistamines. RLS symptoms can cause sleep-onset or sleep-maintenance insomnia, unrestorative sleep and poor quality of life. Comprehensive evaluation and medication review by health care providers should be performed in all patients with sleep disturbances.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien: American Academy of Sleep Medicine; 2014.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.
Bliwise DL, Zhang RH, Kutner NG. Medications associated with restless legs syndrome: a case control study in the US renal data system (USRDS). Sleep Med. 2014;15(10):1241–5.
Khatwa U, Kothare SV. Restless legs syndrome and periodic limb movements disorder in the pediatric population. Curr Opin Pulm Med. 2010;16:559–67.
Kliegman R, Stanton B, St. Geme JW, Schor NF, Behrman RE. Nelson textbook of pediatrics. 20th ed. Philadelphia: Elsevier; 2016. Chapter 587.
Mackie S, Winkelman JW. Long-term treatment of restless legs syndrome (RLS): an approach to management of worsening symptoms, loss of efficacy, and augmentation. CNS Drugs. 2015;29(5):351–7.
Rottach KG, Schaner BM, Kirch MH, Zivotofsky AZ, Teufel LM, Gallwitz T, Messer T. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res. 2009;43(1):70–5.
Sheldon S, Kryger M, Ferber R, Gozal D. Principles and practice of pediatric sleep medicine. 2nd ed. Philadelphia: Saunders; 2014. Chapter 43.
Silber MH, Becker PM, Earley C, Garcia-Borreguero D, Ondo WG, Medical Advisory Board of the Willis-Ekbom Disease Foundation. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. Mayo Clin Proc. 2013;88(9):977–86.
Tilma J, Tilma K, Norregaard O, Ostergaard JR. Early childhood-onset restless legs syndrome: symptoms and effect of oral iron treatment. Acta Paediatr. 2013;102(5):221–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Basora, E., Wani, A., Naqvi, S.K. (2019). RLS Caused by Over-the-Counter Medications/Bruises on My Legs. In: Khawaja, I., Hurwitz, T. (eds) Comorbid Sleep and Psychiatric Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-11772-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-030-11772-6_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11771-9
Online ISBN: 978-3-030-11772-6
eBook Packages: MedicineMedicine (R0)